Current knowledge on HPV sampling
Friday, June 17, 2016
Oral Communications
•
OC 12
•
5:30 PM
>
7:50 PM
•
Current knowledge on HPV sampling
•
Mozart 4-5
Oral Communications
•
OC 12-01
•
HPV prevalence amongst Danish HPV self-sampling women stratified by screening history and compared to women undergoing routine screening
See abstract
>
H.
Helle
Pedersen
•
OC 12-02
•
HPV genotype distribution among women with ≥ CIN2: comparison of primary screened women and under-screened women offered self-sampling
See abstract
>
L.
Lena
De Thurah
•
OC 12-03
•
Accessing*: self-sampling and HPV oncoprotein testing combined with genotyping for HPV epidemiology in rural settings
See abstract
>
A.
Amrei
Krings
•
OC 12-04
•
Age-specific hrHPV detection using cervical, vaginal and urine samples of women attending routine cervical screening. One sample doesn’t fit all?
See abstract
>
G.
Grazyna alicja
Stanczuk
•
OC 12-05
•
Cervical screening in rural Malawi using XPERT® HPV and self-taken vaginal samples
See abstract
>
H.
Heather
Cubie
•
OC 12-06
•
Validation of a new HPV self-sampling device: the cervical and self-sample in screening (Cassis) study
See abstract
>
M.
Mariam
El-Zein
•
OC 12-07
•
Evaluation of high risk HPV DNA detection in self-collected vaginal samples and urine from test-of-cure setting
See abstract
>
S.
Sonia
Andersson
•
OC 12-08
•
First-void urine and physician-taken smear show similar sensitivity for the detection of CIN2+ lesions
See abstract
>
W.
Wim
Quint
•
OC 12-10
•
Validation of the FAM19A4/MIR124-2 DNA methylation test for both lavage-and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women
See abstract
>
L.
Lise
De Strooper
•
OC 12-11
•
Validation study of self-collected vaginal dry swabs using the Xpert HPV assay for human papillomavirus detection
See abstract
>
R.
Rosa
Catarino
•
OC 12-12
•
Agreement of vaginal self-sampling and physician-collected HPV test in women attending a colposcopy clinic in Thailand
See abstract
>
N.
Natacha
Phoolcharoen
•
OC 12-13
•
CONFIDENCE™ HPV test validation for QVINTIP self-collected vaginal sample
See abstract
>
M.
Márta
Benczik
•
OC 12-14
•
Comparative study of the determination of HPV test: self-sampling vs urine vs liquid medium cytology
See abstract
>
J.
Jose Manuel
Ramon Cajal
•
OC 12-15
•
FAM19A4 methylation analysis in self-collected samples compared to physician-taken cervical scrapes for detection of cervical (pre)cancer in hrHPV-positive women
See abstract
>
P.
Peter
Snijders
•
OC 12-16
•
Novel DNA hypermethylation markers are feasible in both cervicovaginal lavages and cervical scrapings
See abstract
>
E.
Ed
Schuuring
•
OC 12-17
•
Acceptability of HPV testing using a self-sampling device in non-attendees of municipal cervical cancer screening in Japan
See abstract
>
M.
Mari
Ito
•
OC 12-18
•
Acceptability of self-sampling for cervical cancer screening by health care providers in the accessing program
See abstract
>
A-L.
Anna-lisa
Behnke
•
OC 12-19
•
Modern technology-based communication platforms are well accepted for screening participationof non-attenders through self-sampling
See abstract
>
J.
Janni
Lam
•
OC 12-09
•
THE CLINICAL VALUE OF HPV GENOTYPING IN TRIAGE OF WOMEN WITH HIGH-RISK-HPV-POSITIVE SELF-SAMPLES
See abstract
>
R.
Renee
Ebisch
|